Antony C. Mattessich is CEO & President at OCULAR THERAPEUTIX, INC (OCUL). They have made 8 open-market trades across 1 company since 2017, most recently 2026-06-11.
CIK 0001709900
6 open-market purchases totalling $501K since 2017, against 2 sales. Across 6 scored buys the stock is down 4.1% at ninety days, and 4.6 points behind the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 67% | 83% | 33% |
| Avg Move | +3.1% | +10.1% | -4.1% |
| Alpha | +2.4% | +9.3% | -4.6% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OCUL | SELL · Routine | 2024-02-05 | 2024-02-06 | $4.86 | $95K | +49.5% | +104.5% | +14.4% |
| OCUL | SELL | 2024-01-31 | 2024-02-02 | $4.95 | $182K | +28.2% | +115.9% | +16.5% |
| OCUL | BUY | 2023-08-30 | 2023-09-05 | $3.81 | $25K | -11.9% | -24.6% | -14.9% |
| OCUL | SELL | 2023-02-06 | 2023-02-08 | $4.24 | $167K | +40.3% | +19.1% | +60.1% |
| OCUL | BUY | 2021-08-20 | 2021-08-24 | $9.89 | $49K | +5.2% | +4.5% | -37.2% |
| OCUL | BUY | 2019-06-06 | 2019-06-10 | $2.81 | $112K | +20.1% | +54.7% | +25.3% |
| OCUL | BUY | 2018-08-20 | 2018-08-21 | $5.95 | $119K | +7.1% | +2.1% | -16.8% |
| OCUL | BUY | 2018-08-10 | 2018-08-13 | $6.23 | $105K | +2.5% | +4.9% | -15.9% |
| OCUL | BUY | 2017-12-12 | 2017-12-13 | $4.29 | $90K | -4.3% | +19.1% | +34.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.